Boewe, A.S.; Wemmert, S.; Kulas, P.; Schick, B.; Götz, C.; Wrublewsky, S.; Montenarh, M.; Menger, M.D.; Laschke, M.W.; Ampofo, E.
Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma. Biomedicines 2022, 10, 966.
https://doi.org/10.3390/biomedicines10050966
AMA Style
Boewe AS, Wemmert S, Kulas P, Schick B, Götz C, Wrublewsky S, Montenarh M, Menger MD, Laschke MW, Ampofo E.
Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma. Biomedicines. 2022; 10(5):966.
https://doi.org/10.3390/biomedicines10050966
Chicago/Turabian Style
Boewe, Anne S., Silke Wemmert, Philipp Kulas, Bernhard Schick, Claudia Götz, Selina Wrublewsky, Mathias Montenarh, Michael D. Menger, Matthias W. Laschke, and Emmanuel Ampofo.
2022. "Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma" Biomedicines 10, no. 5: 966.
https://doi.org/10.3390/biomedicines10050966
APA Style
Boewe, A. S., Wemmert, S., Kulas, P., Schick, B., Götz, C., Wrublewsky, S., Montenarh, M., Menger, M. D., Laschke, M. W., & Ampofo, E.
(2022). Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma. Biomedicines, 10(5), 966.
https://doi.org/10.3390/biomedicines10050966